Organon & Co. (NYSE:OGN), a global healthcare company spun off from Merck (NSE:PROR) in 2021, has established itself as a leader in women's health while expanding its presence in biosimilars and ...

The company has captured a 5% share of the biosimilars market for Humira ... are seeking alternatives to long-term steroid use due to potential side effects, and VTAMA could fill this need.

Rosacea Treatment Market Valued at USD 2.07B in 2023, the market is forecast to grow at a CAGR of 6.64% from 2024 to 2032, driven by rising ...

One in 60 people in the U.S. lives with a traumatic brain injury related disability. Here, we discuss the long-term effects ...

AbbVie has put together a dream team of eight big-selling drugs that it says will end its reliance on its blockbuster Humira – which despite tougher competition could still generate peak sales ...

Novartis' Sandoz division has filed its biosimilar of Humira in the US ... and is preparing to file its own long-acting psoriasis drug.

Illustrations are based on personal contract hire, 9 month upfront fee, 48 month term, 8000 miles annually, inc VAT, excluding fees. Vehicle returned at term end. Auto Express "Find a Car" is ...

According to Airbnb, more travelers are now searching the platform for stays longer than 28 days, and as of 2020, over 80 percent of hosts now offer long-term stay options. On Airbnb, hosts are ...

Where do I start.... This is a horribly run company. My mother has a Long Term Health Care plan. I have had 4 incidents with their accounting practices.. They were unable to correctly calculate ...